Aptus Capital Advisors’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
10,739
+210
+2% +$14.7K ﹤0.01% 707
2026
Q1
$795K Sell
10,529
-128
-1% -$9.13K 0.01% 620
2025
Q4
$658K Buy
10,657
+267
+3% +$15.7K ﹤0.01% 672
2025
Q3
$610K Sell
10,390
-563
-5% -$32.8K ﹤0.01% 656
2025
Q2
$638K Buy
10,953
+6
+0.1% +$339 0.01% 628
2025
Q1
$544K Sell
10,947
-335
-3% -$17.1K 0.01% 619
2024
Q4
$511K Buy
+11,282
New +$536K 0.01% 629

Other funds holding NTR

Aptus Capital Advisors's NTR Position: Q2 2026 in Review

Aptus Capital Advisors increased its Nutrien (NTR) stake by 2% in Q2 2026, buying an estimated $14.7K and bringing the position to 10,739 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Aptus Capital Advisors first reported a position in NTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $795K in Q1 2026. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Aptus Capital Advisors held 10,739 shares of Nutrien worth $676K as of Q2 2026.
  • Aptus Capital Advisors bought 210 Nutrien shares in Q2 2026, an estimated $14.7K.
  • Nutrien made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #707 holding.
  • Aptus Capital Advisors first reported a position in Nutrien in Q4 2024 and has held it in 7 quarters since.
  • Aptus Capital Advisors's Nutrien position peaked at $795K in Q1 2026.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.